ライフサイエンスコーパス: clonazepam

1 hibition with picrotoxin or enhanced it with clonazepam.

2 r sertraline plus placebo or sertraline plus clonazepam.

3 d sertraline plus placebo or sertraline plus clonazepam.

4 One-half of these patients received clonazepam, 0.5 mg h.s. adjusted to two tablets by day 1

5 to groups receiving either 0.5 mg of active clonazepam 3 times daily or placebo clonazepam for the f

6 to 3.0 mg/day of clonazepam (sertraline plus clonazepam), a switch to up to 225 mg/day of venlafaxine

7 red network firing pattern was normalized by clonazepam, a positive modulator of the GABAA receptor.

8 27% of patients assigned to sertraline plus clonazepam achieved remission compared with patients ass

9 nt GABA neuronal response to benzodiazepine (clonazepam) administration.

10 Midazolam, but not clonazepam, also augmented a form of spike inhibition af

11 compared midazolam, an anesthetic BDZ, with clonazepam, an anticonvulsant/anxiolytic BDZ that activa

12 A(A) receptor positive allosteric modulators clonazepam and allopregnanolone, and by the NMDA recepto

13 d group received a single oral dose of 0.5mg clonazepam, and the remaining patients received placebo.

14 Clonazepam augmentation correlated positively with the r

15 ach efficacy, the authors determined whether clonazepam augmentation of fluoxetine is superior to flu

16 Clonazepam augmentation of fluoxetine was superior to fl

17 The findings suggest that the clonazepam augmentation strategy provides relative benef

18 of mitochondrial Na(+)/Ca(2+) exchange with clonazepam blocked mitochondrial Ca(2+) efflux and resul

19 We confirm the effectiveness of clonazepam, but note that attention to the safety of the

20 2 microM) and the Na+/Ca2+ exchange blocker, clonazepam, (CLO, 20 microM) reversibly inhibited both t

21 oms can be safely achieved with a sertraline/clonazepam combination, supporting the clinical utility

22 r proportion of responders in the sertraline/clonazepam compared with the sertraline/placebo group at

23 he thalamic effects of the anti-absence drug clonazepam (CZP) are restricted to either relay or retic

24 CAP A3 and, partially, A2 subtypes), whereas clonazepam did the opposite, reducing non-rapid eye move

25 The clonazepam dose was then tapered during 3 weeks and disc

26 f variance confirmed a significant effect of clonazepam for average Hamilton depression scores.

27 f active clonazepam 3 times daily or placebo clonazepam for the first 4 weeks of the trial.

28 in the sertraline/placebo vs the sertraline/clonazepam group (38% vs 25%) (P =.5).

29 roportion of patients in the sertraline plus clonazepam group (56%) compared with the sertraline plus

30 week 3 with 14 (63%) of 22 of the sertraline/clonazepam group responding to treatment vs 8 (32%) of 2

31 Clonazepam had similar effects as CGP37157.

32 The patients taking clonazepam improved significantly more during the first

33 Midazolam, but not clonazepam, increased neurosteroid levels in CA1 pyramid

34 al period (occasionally prenatally) and that clonazepam is the treatment of choice (95% found it to b

35 7157 (CGP)], a benzothiazepine derivative of clonazepam, is commonly used as a blocker of the mitocho

36 o distinct cell populations that differed in clonazepam modulation and patterns of alpha-subunit expr

37 mmonly cited RBD treatments include low-dose clonazepam or high-dose melatonin taken orally at bedtim

38 f GABAergic transmission with tiagabine plus clonazepam partially rescues the effects of deletion of

39 Clonazepam/placebo was gradually discontinued during day

40 died, such as ketamine, midazolam, diazepam, clonazepam, propofol, pentobarbital, chloral hydrate, ha

41 levodopa, rotigotine, clozapine, duloxetine, clonazepam, ramelteon, gabapentin, zonisamide, and yokuk

42 e alone: the addition of up to 3.0 mg/day of clonazepam (sertraline plus clonazepam), a switch to up

43 10 were randomly assigned to sertraline plus clonazepam, switch to venlafaxine, or sertraline plus pl

44 Clonazepam treatment of RBD was completely or partially

45 tetrabenazine (one); and the introduction of clonazepam (two).

46 nerally similar, except for a notably higher clonazepam use in dementia convertors (OR = 2.6).

47 Sertraline plus clonazepam was associated with a significantly greater d

48 selective TSPO agonist, or a combination of clonazepam with exogenous allopregnanolone.

49 ic effects were mimicked by a combination of clonazepam with FGIN (2-[2-(4-fluorophenyl)-1H-indol-3-y

50 st the efficacy of early coadministration of clonazepam with sertraline in the treatment of panic dis